By promoting insulin release and inhibiting glucagon secretion, GLP-1 agonists effectively lower blood sugar levels, providing a valuable therapeutic option for individuals with type 2 diabetes
Knowing about side effects up front is one of the best ways to manage them well, says Chatham
GLP-1 drugs mimic a hormone the body produces after eating, which can decrease appetite and lead to feelings of fulness a major reason people lose weight
A lower-dose GLP-1/GIP protocol designed for women who want metabolic benefits energy, focus, sleep, lean body composition without aggressive weight loss
Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetesrandomized controlled trial
Your body gets significantly fewer vitamins from food